Guest Column: Device Firms Stryker Instruments, HeartWare Invest In Employee Soft Skills – And Reap Big Rewards
This article was originally published in The Gray Sheet
Executive Summary
Manufacturers would be wise to train employees on how to effectively communicate with colleagues and FDA, guest columnist Mitzi Perdue says, noting that so-called soft skills such as effective and active listening, critical thinking, effective writing, and influential speaking can be extremely effective in solving an array of problems. "To advance in our company and be successful, you must develop soft skills … this is happening all over industry," Bob Yocher, VP of regulatory affairs for device-maker HeartWare, tells Perdue in this "Gray Sheet" Medtech Talk column.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.